Interacciones entre el pomelo y los medicamentos

1. Bailey DG, Spence JD, Edgar B, et al. Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med 1989; 12: 357- 62.

2. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice–Drug interactions. Br J Clin Pharmacol 1998;46:101-10.

3. Bailey DG, Spence JD, Munoz C, et al. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9.

4. Bailey DG. Fruit juice inhibition of uptake transport: a new type of food–drug interaction. Br J Clin Pharmacol 2010;70:645-55.

5. Wilkinson GR. Drug metabolism and variability among patients in drug response. N Engl J Med 2005;352:2211-21.

6. Edgar B, Regardh CG, Johnsson G, et al. Felodipine kinetics in healthy man. Clin Pharmacol Ther 1985;38:205-11.

7. Guo LQ, Yamazoe Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol Sin 2004;25:129-36.

8. Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997; 99: 2545- 53.

9. Lundahl J, Regardh CG, Edgar B, et al. Effects of grapefruit juice ingestion — pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 1997;52:139-45.

10. Ducharme MP, Warbasse LH, Edwards DJ. Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther 1995;57:485-91.

11. Edgar B, Bailey D, Bergstrand R, et al. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine and its potential clinical relevance. Eur J Clin Pharmacol 1992; 42: 313-7.

12. Bailey DG, Dresser GK, Kreeft JH, et al. Grapefruit–felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther 2000;68:468-77.

13. Malhotra S, Bailey DG, Paine MF, et al. Seville orange juice– felodipine interaction: comparison with dilute grapefruit juice and involvement of the furanocoumarins. Clin Pharmacol Ther 2001; 69:14-23.

14. Bailey DG, Dresser GK, Bend JR. Bergamottin, lime juice and red wine as inhibitors of CYP3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther 2003;73:529-37.

15. Guo LQ, Chen QY, Wang X, et al. Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine. Curr Drug Metab 2007;8:623-30.

16. Lundahl J, Regardh CG, Edgar B, et al. Relationship between time of intake of grapefruit juice and its effect on pharmaco - kinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 1995;49:61-7.

17. Takanaga H, Ohnishi A, Murakami H, et al. Relationship between time after intake of grapefruit juice and the effect on the pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects. Clin Pharmacol Ther 2000;67:201-14.

18. Agosti S, Casalino L, Bertero G, et al. A dangerous fruit juice. Am J Emerg Med 2012;30:248.e5-248.e8.

19. Hermans K, Stockman D, Van den Branden F. Grapefruit and tonic: a deadly combination in a patient with the long QT syndrome. Am J Med 2003;114:511-2.

20. Pillai U, Muzaffar J, Sen S, et al. Grapefruit juice and verapamil: a toxic cocktail. South Med J 2009;102:308-9.

21. Mazokopakis EE. Unusual causes of rhabdomyolysis. Intern Med J 2008;38:364-7.

22. Karch AM. The grapefruit challenge: the juice inhibits a crucial enzyme, with possibly fatal consequences. Am J Nurs 2004; 104:33-5.

23. Dreier JP, Endres M. Statin-associated rhabdomyolysis triggered by grapefruit consumption. Neurology 2004;62:670.

24. Peynaud D, Charpiat B, Vial T, et al. Tacrolimus severe overdosage after intake of masked grapefruit in orange marmalade. Eur J Clin Pharmacol 2007;63:721-2.

25. Goldbart A, Press J, Sofer S, et al. Near fatal acute colchicine in - toxication in a child. A case report. Eur J Pediatr 2000; 159:895-7.

26. Grande LA, Mendez RD, Krug RT, et al. Attention grapefruit! Lancet 2009;373:1222.<